Schisandra chinensis alleviates Hypertriglyceridemia in nonalcoholic fatty liver disease by modulating the gut microbiota and hepatic lipid metabolism: identification of its active fractions

作者
Qi Li,Mei Feng,Qi luo,Chen Yalin Ye,Yi Ke Luo,Yuling Xu
出处
期刊:Frontiers in Pharmacology [Frontiers Media]
卷期号:16: 1715364-1715364 被引量:5
标识
DOI:10.3389/fphar.2025.1715364
摘要

Background Nonalcoholic fatty liver disease (NAFLD) is a prevalent metabolic disorder characterized by hepatic lipid accumulation and gut microbiota dysbiosis. Schisandra chinensis (Turcz.) Baill. (SCH), a traditional hepatoprotective herb, has shown therapeutic potential; however, its mechanisms in NAFLD remain incompletely understood. Objective To investigate the protective effects and underlying mechanisms of SCH against NAFLD through integrated genetic, experimental, and multi-omics approaches. Methods Mendelian randomization (MR) analysis based on large-scale genome-wide association study (GWAS) datasets was performed to evaluate the causal effects of lipid traits on NAFLD risk. An HFD-induced NAFLD mouse model was used to assess the therapeutic efficacy of SCH extract, with evaluations of serum lipid profiles, liver function, and histopathology. Multi-omics analyses—including 16S rRNA sequencing, untargeted lipidomics, and hepatic metabolite profiling (LC-MS/MS)—were integrated with network pharmacology to predict active metabolite–target–pathway interactions. In vitro , an FFA-induced HepG2 steatosis model was used to screen the bioactive fractions of SCH. Results SCH significantly reduced hepatic TG accumulation and improved serum lipid profiles. MR analysis confirmed TG as a causal factor for NAFLD. SCH intervention enriched beneficial taxa (e.g., Turicibacter, Muribaculaceae) while suppressing HFD-induced dysbiosis. Lipidomics revealed modulation of glycerophospholipid and choline metabolism. Key phytometabolites (e.g., schisandrin B, gomisin N) were correlated with microbial composition and lipid remodeling. Network pharmacology identified putative targets involved in lipid metabolism, inflammation, and neuroendocrine signaling (e.g., PTGS2, GABRA1, ESR1). GO and KEGG enrichment supported roles in oxidative stress, steroid hormone signaling, and GABAergic synapse pathways, consistent with experimental multi-omics results. In vitro assays demonstrated that the n-butanol (BuOH) fraction was the principal bioactive component, significantly reducing lipid accumulation in HepG2 cells. Conclusion This integrative study demonstrates that SCH protects against NAFLD by lowering triglycerides, remodeling the gut–liver axis, and reprogramming hepatic lipid metabolism. The BuOH fraction constitutes the main active component, supporting SCH as a promising multi-target candidate for NAFLD therapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Maestro_S的应助被小鱼干采纳,获得10
1秒前
1秒前
吕锴岐完成签到 ,获得积分10
2秒前
huang完成签到 ,获得积分10
2秒前
2秒前
zjjcug完成签到,获得积分10
2秒前
苦昼短完成签到 ,获得积分10
2秒前
zzl完成签到,获得积分10
2秒前
大个的应助被小青采纳,获得10
3秒前
anqi6688完成签到,获得积分10
3秒前
Zzha10完成签到,获得积分10
3秒前
CarryLJR发布了新的文献求助10
3秒前
充电宝的应助被生而追梦不止采纳,获得10
4秒前
张伟的应助被漫漫采纳,获得10
5秒前
6秒前
6秒前
天才发布了新的文献求助10
7秒前
8秒前
衣锦夜行完成签到,获得积分10
10秒前
完美世界的应助被是小鱼采纳,获得10
10秒前
汉堡包的应助被11NING采纳,获得10
10秒前
hanks完成签到,获得积分10
11秒前
Largequail完成签到,获得积分10
12秒前
啦啦啦发布了新的文献求助10
12秒前
衣锦夜行发布了新的文献求助10
14秒前
李爱国的应助被乐观阑悦采纳,获得10
14秒前
李健的应助被合适的咖啡采纳,获得10
14秒前
Savananh_Xie发布了新的文献求助10
14秒前
啦啦啦啦啦完成签到 ,获得积分10
14秒前
15秒前
Aria完成签到,获得积分10
16秒前
16秒前
若即若离完成签到,获得积分10
17秒前
yeo完成签到 ,获得积分10
18秒前
回眸完成签到 ,获得积分10
18秒前
zz发布了新的文献求助10
19秒前
sun完成签到,获得积分10
19秒前
张伟的应助被是我呀吼采纳,获得10
19秒前
深情安青的应助被Zzha10采纳,获得10
19秒前
Kris完成签到 ,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181658
求助须知:如何正确求助?哪些是违规求助? 9571454
关于积分的说明 21818081
捐赠科研通 7777987
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479568